The immune system in COPD: guilty as charged?

Wim Timens (Groningen, Netherlands)

Source: International Congress 2016 – Immunity in COPD
Session: Immunity in COPD
Session type: Hot topics
Number: 4783
Disease area: Airway diseases

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Wim Timens (Groningen, Netherlands). The immune system in COPD: guilty as charged?. International Congress 2016 – Immunity in COPD

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Adaptive immune system in COPD: auto-immunity or bystander?
Source: Annual Congress 2012 - ERS COPD Research Award Ceremony (supported by Boehringer Ingelheim) followed by the Hot Topic "It takes two to tango: innate and adaptive immunity in COPD"
Year: 2012


The gut-flora in health and disease: interactions with the immune system
Source: Annual Congress 2005 - Microorganisms: good, bad or ugly in allergic respiratory disease
Year: 2005

"Don’t get me wrong, I think case finding is okay" Exploring healthcare professionals’ perspectives on target case-finding for COPD
Source: International Congress 2016 – Screening, diagnosis, assessment, and treatment of COPD in primary care
Year: 2016

Evasion of COPD in smokers: at what price?
Source: Eur Respir J 2012; 39: 1298-1303
Year: 2012



Ageing of the immune system: a contribution to lung disease?
Source: Annual Congress 2012 - Searching for the secrets of senescence in the lung
Year: 2012

Cardiovascular disease and COPD: dangerous liaisons?
Source: Eur Respir Rev, 27 (149) 180057; 10.1183/16000617.0057-2018
Year: 2018



Blocking innate immunity in humans: wise or foolish?
Source: Lung Science Conference 2004 - Application of our knowledge of the basic processes of lung inflammation in lung diseases
Year: 2004


Eosinophils in COPD: do they predict drug response?
Source: International Congress 2018 – State of the art session: Airways disease
Year: 2018


COPD and bronchodilators: should the heart pay the bill for the lung?
Source: Eur Respir J, 49 (5) 1700370; 10.1183/13993003.00370-2017
Year: 2017



Can the immune system be targeted to treat COVID-19?
Source: Eur Respir Monogr 2021; 94: 69-85
Year: 2021


The adaptive immune system, autoimmunity and COPD: lessons from human studies
Source: Annual Congress 2007 - T- and B-cells in COPD: a role for adaptive immunity in the pathogenesis of COPD?
Year: 2007


Innate immunity in COPD: too much or too little?
Source: Annual Congress 2007 - T- and B-cells in COPD: a role for adaptive immunity in the pathogenesis of COPD?
Year: 2007


Community acquired pneumonia in COPD patients: ?linical features and peculiarities of immune system
Source: International Congress 2019 – Airway infection in COPD
Year: 2019

COPD: Still a Cinderella?
Source: Eur Respir J 2003; 22: Suppl. 45, 67s
Year: 2003

“When you’re at work you’ve got a goal [..] but that’s all finished for me now”; exploring goal perception amongst people with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2017 – Latest insights into chronic care
Year: 2017

Investigation the role of pentraxin-3 in the innate immune system in patients with COPD
Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease
Year: 2015


The adaptive immune system, autoimmunity and COPD: lessons from animal models
Source: Annual Congress 2007 - T- and B-cells in COPD: a role for adaptive immunity in the pathogenesis of COPD?
Year: 2007